How Charge, Size and Protein Corona Modulate the Specific Activity of Nanostructured Lipid Carriers (NLC) against <i>Helicobacter pylori</i>
The major risk factor associated with the development of gastric cancer is chronic infection with <i>Helicobacter pylori</i>. The available treatments, based on a cocktail of antibiotics, fail in up to 40% of patients and disrupt their gut microbiota. The potential of blank nanostructure...
Saved in:
Main Authors: | Rute Chitas (Author), Cláudia Nunes (Author), Salette Reis (Author), Paula Parreira (Author), Maria Cristina L. Martins (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Entrapment efficiency and drug loading of curcumin nanostructured lipid carrier (NLC) formula
by: Rabima Rabima, et al.
Published: (2019) -
In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
by: Cláudia Pina Costa, et al.
Published: (2021) -
Encapsulation of Vitamin A Palmitate in Nanostructured Lipid Carrier (NLC)-Effect of Surfactant Concentration on the Formulation Properties
by: Akram Pezeshki, et al.
Published: (2014) -
Effect of Lipid Ratio of Stearic Acid and Oleic Acid on Characteristics of Nanostructure Lipid Carrier (NLC) System of Diethylammonium Diclofenac
by: Esti Hendradi, et al.
Published: (2017) -
Short Term Stability Testing of Efavirenz-Loaded Solid Lipid Nanoparticle (SLN) and Nanostructured Lipid Carrier (NLC) Dispersions
by: Pedzisai A. Makoni, et al.
Published: (2019)